Evidence map›Paper›PMID 34571852›Full record

ArticleCells2021

Snail Upregulates Transcription of FN, LEF, COX2, and COL1A1 in Hepatocellular Carcinoma: A General Model Established for Snail to Transactivate Mesenchymal Genes.

Tam Minh Ly, Yen-Cheng Chen, Ming-Che Lee, Chi-Tan Hu, Chuan-Chu Cheng, Hsin-Hou Chang, Ren-In You, Wen-Sheng Wu

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tam Minh LyInstitute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan.
Yen-Cheng ChenDivision of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Ming-Che LeeDivision of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Chi-Tan HuDivision of Gastroenterology, Department of Medicine, Research Centre for Hepatology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.ORCID 0000-0002-6292-1521
Chuan-Chu ChengDepartment of Laboratory Medicine and Biotechnology, College of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Hsin-Hou ChangDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan.ORCID 0000-0002-8731-3485
Ren-In YouDepartment of Laboratory Medicine and Biotechnology, College of Medicine, Tzu Chi University, Hualien 970, Taiwan.ORCID 0000-0002-6289-1852
Wen-Sheng WuDivision of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.ORCID 0000-0002-8983-6458
Tzu Chi University · TWTzu Chi Foundation · TW

Funding

Buddhist Tzu Chi Medical Foundation TCMMP108-03-02Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical foundation TCRD110-71
6 · The paper itself

Abstract

SNA is one of the essential EMT transcriptional factors capable of suppressing epithelial maker while upregulating mesenchymal markers. However, the mechanisms for SNA to transactivate mesenchymal markers was not well elucidated. Recently, we demonstrated that SNA collaborates with EGR1 and SP1 to directly upregulate MMP9 and ZEB1. Remarkably, a SNA-binding motif (TCACA) upstream of EGR/SP1 overlapping region on promoters was identified. Herein, we examined whether four other mesenchymal markers, lymphoid enhancer-binding factor (LEF), fibronectin (FN), cyclooxygenase 2 (COX2), and collagen type alpha I (COL1A1) are upregulated by SNA in a similar fashion. Expectedly, SNA is essential for expression of these mesenchymal genes. By deletion mapping and site directed mutagenesis coupled with dual luciferase promoter assay, SNA-binding motif and EGR1/SP1 overlapping region are required for TPA-induced transcription of LEF, FN, COX2 and COL1A1. Consistently, TPA induced binding of SNA and EGR1/SP1 on relevant promoter regions of these mesenchymal genes using ChIP and EMSA. Thus far, we found six of the mesenchymal genes are transcriptionally upregulated by SNA in the same fashion. Moreover, comprehensive screening revealed similar sequence architectures on promoter regions of other SNA-upregulated mesenchymal markers, suggesting that a general model for SNA-upregulated mesenchymal genes can be established.

Indexed as

Carcinoma, HepatocellularCell LineCollagen Type ICollagen Type I, alpha 1 ChainCyclooxygenase 2FibronectinsGene ExpressionGene Expression Regulation, NeoplasticHep G2 CellsHumansLiver NeoplasmsLymphoid Enhancer-Binding Factor 1Mesenchymal Stem CellsPromoter Regions, GeneticProtein BindingSnail Family Transcription FactorsCollagen Type ICollagen Type I, alpha 1 ChainCyclooxygenase 2FibronectinsFN1 protein, humanLEF1 protein, humanLymphoid Enhancer-Binding Factor 1SNAI1 protein, humanSnail Family Transcription FactorsTranscription Factorscollagen type alpha Icyclooxygenase 2fibronectinlymphoid enhancer-binding factorsnailtranscription

Identifiers

PMID34571852
PMCPMC8467536
OpenAlexW3198457522

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.